Prostate cancer is the most common neoplasm in men in western countries.
FREE DAILY AND WEEKLY NEWSLETTERS OFFERED BY CONTENT OF INTEREST
Did you find this article relevant? Subscribe to UroToday-GUOncToday!
The fields of GU Oncology and Urology are advancing rapidly including new treatments, enrolling clinical trials, screening and surveillance recommendations along with updated guidelines. Join us as one of our subscribers who rely on UroToday as their must-read source for the latest news and data on drugs. Sign up today for blogs, video conversations, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.
The use of strategies for primary prevention and early diagnosis is a usual procedure, but there is considerable controversy on their benefits. Recent data from several remarkable studies have contributed more uncertainty toward this issue. We review the available evidence and suggest some general recommendations for prostate cancer primary prevention and screening.
Pinto Á, Pérez Segura P. Are you the author?
Medical Oncology Department, University Hospital La Paz, IdiPAZ bMedical Oncology Department, University Hospital Clínico San Carlos, Madrid, Spain.
Reference: Eur J Cancer Prev. 2015 Mar 19. Epub ahead of print.